LRG Staff

/LRG Staff

About LRG Staff

This author has not yet filled in any details.
So far LRG Staff has created 401 blog entries.

LRG Webcast Series: Updates on the Temozolomide Trial

Dr. Jason Sicklick of Moores Cancer Center at the University of California San Diego talks about the Phase II study of Temozolomide (TMZ) in advanced SDH-mutant/deficient GIST, a new study available to patients with SDH-deficient GIST.

By |2019-09-16T16:29:29-04:00September 16th, 2019|Clinical Trials, News, Webcast|